Investment Analysts’ Weekly Ratings Changes for Synopsys (SNPS)

Several analysts have recently updated their ratings and price targets for Synopsys (NASDAQ: SNPS):

  • 9/25/2026 – Synopsys was upgraded by Roth Capital to “buy”.
  • 9/25/2026 – Synopsys was downgraded by HSBC Holdings plc from “buy” to “reduce”.
  • 9/25/2026 – Synopsys was downgraded by KeyCorp from “overweight” to “strong sell”.
  • 9/25/2026 – Synopsys is now covered by Sanford C. Bernstein. They set an “outperform” rating on the stock.
  • 9/25/2026 – Synopsys is now covered by Barclays PLC. They set an “overweight” rating on the stock.
  • 9/25/2026 – Synopsys was upgraded by HSBC Holdings plc from “hold” to “buy”. They now have a $700.00 price target on the stock, up from $490.00.
  • 9/24/2026 – Synopsys was upgraded by BNP Paribas Exane from “underperform” to “neutral”. They now have a $420.00 price target on the stock.
  • 9/11/2026 – Synopsys was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
  • 9/10/2026 – Synopsys was upgraded by Wells Fargo & Company from “equal weight” to “overweight”. They now have a $475.00 price target on the stock, up from $450.00.
  • 8/27/2026 – Synopsys was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
  • 8/27/2026 – Synopsys was given a new $570.00 price target by UBS Group AG.
  • 8/27/2026 – Synopsys had its price target lowered by Mizuho from $600.00 to $550.00. They now have an “outperform” rating on the stock.
  • 8/27/2026 – Synopsys was upgraded by Robert W. Baird from “neutral” to “outperform”. They now have a $560.00 price target on the stock, up from $558.00.
  • 8/27/2026 – Synopsys had its “buy” rating reaffirmed by Benchmark Co.. They now have a $570.00 price target on the stock.
  • 8/27/2026 – Synopsys had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $580.00 price target on the stock.
  • 8/25/2026 – Synopsys had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $575.00 price target on the stock.
  • 8/21/2026 – Synopsys was downgraded by Zacks Research from “strong-buy” to “hold”.
  • 8/19/2026 – Synopsys had its “buy” rating reaffirmed by Benchmark Co..
  • 8/19/2026 – Synopsys had its price target lowered by Morgan Stanley from $525.00 to $500.00. They now have an “equal weight” rating on the stock.
  • 8/19/2026 – Synopsys had its “overweight” rating reaffirmed by KeyCorp.
  • 8/11/2026 – Synopsys had its price target lowered by Wells Fargo & Company from $535.00 to $450.00. They now have an “equal weight” rating on the stock.

Insider Buying and Selling

In other news, insider Aart de Geus sold 24,641 shares of Synopsys stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the transaction, the insider directly owned 120,443 shares of the company’s stock, valued at $50,518,611.92. The trade was a 16.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,604 shares of the company’s stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the completion of the transaction, the chief executive officer owned 76,865 shares of the company’s stock, valued at approximately $28,815,151.20. The trade was a 15.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 89,245 shares of company stock valued at $37,992,919. 0.56% of the stock is owned by corporate insiders.

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.

Featured Stories

Receive News & Ratings for Synopsys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys Inc and related companies with MarketBeat.com's FREE daily email newsletter.